IQV vs. IDXX

Last updated Apr 2, 2026

Compare and contrast key facts about IQVIA Holdings Inc. (IQV) and IDEXX Laboratories, Inc. (IDXX).

Performance

IQV vs. IDXX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IQVIA Holdings Inc. (IQV) and IDEXX Laboratories, Inc. (IDXX). The values are adjusted to include any dividend payments, if applicable.

IQV vs. IDXX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
IQV IQVIA Holdings Inc.	-23.52%	14.71%	-15.07%	12.93%	-27.38%	57.47%	15.96%	33.00%	18.66%	28.73%
IDXX IDEXX Laboratories, Inc.	-16.54%	63.63%	-25.51%	36.06%	-38.04%	31.73%	91.43%	40.38%	18.95%	33.35%

Fundamentals

Market Cap IQV : $29.64B IDXX : $45.55B
EPS IQV : $7.89 IDXX : $13.12
PE Ratio IQV : 21.84 IDXX : 43.05
PEG Ratio IQV : 1.78 IDXX : 9.81
PS Ratio IQV : 1.82 IDXX : 10.60
PB Ratio IQV : 4.56 IDXX : 28.38
Total Revenue (TTM) IQV : $16.31B IDXX : $4.30B
Gross Profit (TTM) IQV : $4.29B IDXX : $2.66B
EBITDA (TTM) IQV : $3.46B IDXX : $1.47B

Returns By Period

In the year-to-date period, IQV achieves a -23.52% return, which is significantly lower than IDXX's -16.54% return. Over the past 10 years, IQV has underperformed IDXX with an annualized return of 9.83%, while IDXX has yielded a comparatively higher 21.68% annualized return.

IQV

• 1D: 1.09%
• 1M: -1.07%
• YTD: -23.52%
• 6M: -15.40%
• 1Y: 0.68%
• 3Y*: -4.65%
• 5Y*: -2.74%
• 10Y*: 9.83%

IDXX

• 1D: 0.49%
• 1M: -11.31%
• YTD: -16.54%
• 6M: -8.94%
• 1Y: 34.90%
• 3Y*: 4.13%
• 5Y*: 3.03%
• 10Y*: 21.68%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

IQV vs. IDXX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IQV

IQV Risk / Return Rank: 38
IQV Sharpe Ratio Rank: 41
IQV Sortino Ratio Rank: 37
IQV Omega Ratio Rank: 37
IQV Calmar Ratio Rank: 38
IQV Martin Ratio Rank: 38

IDXX

IDXX Risk / Return Rank: 70
IDXX Sharpe Ratio Rank: 68
IDXX Sortino Ratio Rank: 74
IDXX Omega Ratio Rank: 72
IDXX Calmar Ratio Rank: 67
IDXX Martin Ratio Rank: 69

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IQV vs. IDXX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IQVIA Holdings Inc. (IQV) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IQV	IDXX	Difference
Sharpe ratio Return per unit of total volatility	0.02	0.80	-0.79
Sortino ratio Return per unit of downside risk	0.33	1.84	-1.51
Omega ratio Gain probability vs. loss probability	1.04	1.24	-0.19
Calmar ratio Return relative to maximum drawdown	-0.07	1.26	-1.33
Martin ratio Return relative to average drawdown	-0.15	3.45	-3.61
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IQV vs. IDXX - Sharpe Ratio Comparison

The current IQV Sharpe Ratio is 0.02, which is lower than the IDXX Sharpe Ratio of 0.80. The chart below compares the historical Sharpe Ratios of IQV and IDXX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	IQV	IDXX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.02	0.80	-0.79
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.08	0.09	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.32	0.66	-0.35
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.51	-0.12

Correlation

The correlation between IQV and IDXX is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

IQV vs. IDXX - Dividend Comparison

Neither IQV nor IDXX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

IQV vs. IDXX - Drawdown Comparison

The maximum IQV drawdown since its inception was -51.52%, smaller than the maximum IDXX drawdown of -81.42%. Use the drawdown chart below to compare losses from any high point for IQV and IDXX.

Drawdown Indicators

	IQV	IDXX	Difference
Max Drawdown Largest peak-to-trough decline	-51.52%	-81.42%	+29.90%
Max Drawdown (1Y) Largest decline over 1 year	-33.72%	-27.34%	-6.38%
Max Drawdown (5Y) Largest decline over 5 years	-51.52%	-54.00%	+2.48%
Max Drawdown (10Y) Largest decline over 10 years	-51.52%	-54.00%	+2.48%
Current Drawdown Current decline from peak	-39.00%	-26.35%	-12.65%
Average Drawdown Average peak-to-trough decline	-12.41%	-20.98%	+8.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.47%	9.98%	+4.49%

Volatility

IQV vs. IDXX - Volatility Comparison

IQVIA Holdings Inc. (IQV) has a higher volatility of 9.97% compared to IDEXX Laboratories, Inc. (IDXX) at 8.63%. This indicates that IQV's price experiences larger fluctuations and is considered to be riskier than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IQV	IDXX	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.97%	8.63%	+1.34%
Volatility (6M) Calculated over the trailing 6-month period	27.96%	23.61%	+4.35%
Volatility (1Y) Calculated over the trailing 1-year period	43.29%	43.76%	-0.47%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.52%	35.10%	-2.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.24%	32.84%	-1.60%

Financials

IQV vs. IDXX - Profitability Comparison

The chart below illustrates the profitability comparison between IQVIA Holdings Inc. and IDEXX Laboratories, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

IQV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, IQVIA Holdings Inc. reported a gross profit of 292.00M and revenue of 4.36B. Therefore, the gross margin over that period was 6.7%.

IDXX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, IDEXX Laboratories, Inc. reported a gross profit of 658.11M and revenue of 1.09B. Therefore, the gross margin over that period was 60.4%.

IQV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, IQVIA Holdings Inc. reported an operating income of 732.00M and revenue of 4.36B, resulting in an operating margin of 16.8%.

IDXX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, IDEXX Laboratories, Inc. reported an operating income of 315.61M and revenue of 1.09B, resulting in an operating margin of 28.9%.

IQV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, IQVIA Holdings Inc. reported a net income of 514.00M and revenue of 4.36B, resulting in a net margin of 11.8%.

IDXX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, IDEXX Laboratories, Inc. reported a net income of 248.19M and revenue of 1.09B, resulting in a net margin of 22.8%.